Description

Active Ingredient:

• Lastlerge is the FIRST & ONLY Mizolastine in Egypt introduced in market, H1 2nd generation Antihistamine , long acting & non-sedating approved by EMA in treating Allergic Rhinoconjunctivitis and Urticaria in 1996

Indications:

• Lastlerge 10mg used in adult including elderly and children 12 years of age and over (once daily dose) .

 pack:

• Lastlerge available in a pack of 14 tablets.